DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma

Autores
Silva, Adriana L.; Martini, Sabrina V.; Abreu, Soraia C.; Samary, Cynthia S.; Diaz, Bruno L.; Fernezlian, Sandra; Sá, Vanessa Karen de; Capelozzi, Vera Luiza; Boylan, Nicholas J.; Goya, Rodolfo Gustavo; Suk, Jung Soo; Rocco, Patricia R. M.; Hanes, Justin; Morales, Marcelo M.
Año de publicación
2014
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Thymulin has been shown to present anti-inflammatory and anti-fibrotic properties in experimental lung diseases. We hypothesized that a biologically active thymulin analog gene, methionine serum thymus factor, delivered by highly compacted DNA nanoparticles may prevent lung inflammation and remodeling in a mouse model of allergic asthma. The DNA nanoparticles are composed of a single molecule of plasmid DNA compacted with block copolymers of poly-L-lysine and polyethylene glycol (CK30PEG), which have been found safe in a human phase I/II clinical trial. Thymulin plasmids were detected in the lungs of ovalbumin-challenged asthmatic mice up to 27days after administration of DNA nanoparticles carrying thymulin plasmids. A single dose of DNA nanoparticles carrying thymulin plasmids prevented lung inflammation, collagen deposition and smooth muscle hypertrophy in the lungs of a murine model of ovalbumin-challenged allergic asthma, leading to improved lung mechanics. In the present model of chronic allergic asthma, highly compacted DNA nanoparticles using thymulin analog gene modulated the inflammatory and remodeling processes improving lung mechanics.
Instituto de Investigaciones Bioquímicas de La Plata
Materia
Bioquímica
Allergy gene therapy
Thymulin
DNA nanoparticles
Lung remodeling
Nivel de accesibilidad
acceso abierto
Condiciones de uso
http://creativecommons.org/licenses/by-nc-sa/4.0/
Repositorio
SEDICI (UNLP)
Institución
Universidad Nacional de La Plata
OAI Identificador
oai:sedici.unlp.edu.ar:10915/128275

id SEDICI_09bc307e67dae2f7c02385080ec2c4b3
oai_identifier_str oai:sedici.unlp.edu.ar:10915/128275
network_acronym_str SEDICI
repository_id_str 1329
network_name_str SEDICI (UNLP)
spelling DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthmaSilva, Adriana L.Martini, Sabrina V.Abreu, Soraia C.Samary, Cynthia S.Diaz, Bruno L.Fernezlian, SandraSá, Vanessa Karen deCapelozzi, Vera LuizaBoylan, Nicholas J.Goya, Rodolfo GustavoSuk, Jung SooRocco, Patricia R. M.Hanes, JustinMorales, Marcelo M.BioquímicaAllergy gene therapyThymulinDNA nanoparticlesLung remodelingThymulin has been shown to present anti-inflammatory and anti-fibrotic properties in experimental lung diseases. We hypothesized that a biologically active thymulin analog gene, methionine serum thymus factor, delivered by highly compacted DNA nanoparticles may prevent lung inflammation and remodeling in a mouse model of allergic asthma. The DNA nanoparticles are composed of a single molecule of plasmid DNA compacted with block copolymers of poly-L-lysine and polyethylene glycol (CK30PEG), which have been found safe in a human phase I/II clinical trial. Thymulin plasmids were detected in the lungs of ovalbumin-challenged asthmatic mice up to 27days after administration of DNA nanoparticles carrying thymulin plasmids. A single dose of DNA nanoparticles carrying thymulin plasmids prevented lung inflammation, collagen deposition and smooth muscle hypertrophy in the lungs of a murine model of ovalbumin-challenged allergic asthma, leading to improved lung mechanics. In the present model of chronic allergic asthma, highly compacted DNA nanoparticles using thymulin analog gene modulated the inflammatory and remodeling processes improving lung mechanics.Instituto de Investigaciones Bioquímicas de La Plata2014-02-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf125-133http://sedici.unlp.edu.ar/handle/10915/128275enginfo:eu-repo/semantics/altIdentifier/issn/1873-4995info:eu-repo/semantics/altIdentifier/issn/0168-3659info:eu-repo/semantics/altIdentifier/pmid/24556417info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jconrel.2014.02.010info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:30:58Zoai:sedici.unlp.edu.ar:10915/128275Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:30:59.096SEDICI (UNLP) - Universidad Nacional de La Platafalse
dc.title.none.fl_str_mv DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
title DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
spellingShingle DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
Silva, Adriana L.
Bioquímica
Allergy gene therapy
Thymulin
DNA nanoparticles
Lung remodeling
title_short DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
title_full DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
title_fullStr DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
title_full_unstemmed DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
title_sort DNA nanoparticle-mediated thymulin gene therapy prevents airway remodeling in experimental allergic asthma
dc.creator.none.fl_str_mv Silva, Adriana L.
Martini, Sabrina V.
Abreu, Soraia C.
Samary, Cynthia S.
Diaz, Bruno L.
Fernezlian, Sandra
Sá, Vanessa Karen de
Capelozzi, Vera Luiza
Boylan, Nicholas J.
Goya, Rodolfo Gustavo
Suk, Jung Soo
Rocco, Patricia R. M.
Hanes, Justin
Morales, Marcelo M.
author Silva, Adriana L.
author_facet Silva, Adriana L.
Martini, Sabrina V.
Abreu, Soraia C.
Samary, Cynthia S.
Diaz, Bruno L.
Fernezlian, Sandra
Sá, Vanessa Karen de
Capelozzi, Vera Luiza
Boylan, Nicholas J.
Goya, Rodolfo Gustavo
Suk, Jung Soo
Rocco, Patricia R. M.
Hanes, Justin
Morales, Marcelo M.
author_role author
author2 Martini, Sabrina V.
Abreu, Soraia C.
Samary, Cynthia S.
Diaz, Bruno L.
Fernezlian, Sandra
Sá, Vanessa Karen de
Capelozzi, Vera Luiza
Boylan, Nicholas J.
Goya, Rodolfo Gustavo
Suk, Jung Soo
Rocco, Patricia R. M.
Hanes, Justin
Morales, Marcelo M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Bioquímica
Allergy gene therapy
Thymulin
DNA nanoparticles
Lung remodeling
topic Bioquímica
Allergy gene therapy
Thymulin
DNA nanoparticles
Lung remodeling
dc.description.none.fl_txt_mv Thymulin has been shown to present anti-inflammatory and anti-fibrotic properties in experimental lung diseases. We hypothesized that a biologically active thymulin analog gene, methionine serum thymus factor, delivered by highly compacted DNA nanoparticles may prevent lung inflammation and remodeling in a mouse model of allergic asthma. The DNA nanoparticles are composed of a single molecule of plasmid DNA compacted with block copolymers of poly-L-lysine and polyethylene glycol (CK30PEG), which have been found safe in a human phase I/II clinical trial. Thymulin plasmids were detected in the lungs of ovalbumin-challenged asthmatic mice up to 27days after administration of DNA nanoparticles carrying thymulin plasmids. A single dose of DNA nanoparticles carrying thymulin plasmids prevented lung inflammation, collagen deposition and smooth muscle hypertrophy in the lungs of a murine model of ovalbumin-challenged allergic asthma, leading to improved lung mechanics. In the present model of chronic allergic asthma, highly compacted DNA nanoparticles using thymulin analog gene modulated the inflammatory and remodeling processes improving lung mechanics.
Instituto de Investigaciones Bioquímicas de La Plata
description Thymulin has been shown to present anti-inflammatory and anti-fibrotic properties in experimental lung diseases. We hypothesized that a biologically active thymulin analog gene, methionine serum thymus factor, delivered by highly compacted DNA nanoparticles may prevent lung inflammation and remodeling in a mouse model of allergic asthma. The DNA nanoparticles are composed of a single molecule of plasmid DNA compacted with block copolymers of poly-L-lysine and polyethylene glycol (CK30PEG), which have been found safe in a human phase I/II clinical trial. Thymulin plasmids were detected in the lungs of ovalbumin-challenged asthmatic mice up to 27days after administration of DNA nanoparticles carrying thymulin plasmids. A single dose of DNA nanoparticles carrying thymulin plasmids prevented lung inflammation, collagen deposition and smooth muscle hypertrophy in the lungs of a murine model of ovalbumin-challenged allergic asthma, leading to improved lung mechanics. In the present model of chronic allergic asthma, highly compacted DNA nanoparticles using thymulin analog gene modulated the inflammatory and remodeling processes improving lung mechanics.
publishDate 2014
dc.date.none.fl_str_mv 2014-02-17
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Articulo
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://sedici.unlp.edu.ar/handle/10915/128275
url http://sedici.unlp.edu.ar/handle/10915/128275
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/issn/1873-4995
info:eu-repo/semantics/altIdentifier/issn/0168-3659
info:eu-repo/semantics/altIdentifier/pmid/24556417
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jconrel.2014.02.010
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
eu_rights_str_mv openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-sa/4.0/
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
dc.format.none.fl_str_mv application/pdf
125-133
dc.source.none.fl_str_mv reponame:SEDICI (UNLP)
instname:Universidad Nacional de La Plata
instacron:UNLP
reponame_str SEDICI (UNLP)
collection SEDICI (UNLP)
instname_str Universidad Nacional de La Plata
instacron_str UNLP
institution UNLP
repository.name.fl_str_mv SEDICI (UNLP) - Universidad Nacional de La Plata
repository.mail.fl_str_mv alira@sedici.unlp.edu.ar
_version_ 1844616190078484480
score 13.070432